4.6 Article

Coffee Consumption and Risk of Atrial Fibrillation in the Physicians' Health Study

期刊

出版社

WILEY
DOI: 10.1161/JAHA.118.011346

关键词

atrial fibrillation; caffeine; cardiovascular disease; coffee; epidemiology and Nutrition

资金

  1. National Heart, Lung, and Blood Institute [R21HL088081]
  2. National Institutes of Health, Bethesda, MD [CA-34944, CA-40360, CA-097193, HL-26490, HL-34595]

向作者/读者索取更多资源

Background-Although coffee consumption is often reported as a trigger for atrial fibrillation (AF) among patients with paroxysmal AF, prospective studies on the relation of coffee consumption with AF risk have been inconsistent. Hence, we sought to assess the association between coffee consumption and risk of AF in men. Methods and Results-We prospectively studied men who participated in the Physicians' Health Study (N=18 960). Coffee consumption was assessed through self-reported food frequency questionnaires. The incidence of AF was assessed through annual questionnaires and validated through review of medical records in a subsample. Cox proportional hazard models were used to calculate hazard ratios and 95% CIs of AF. The average age was 66.1 years. A total of 2098 new cases of AF occurred during a mean follow-up of 9 years. Hazard ratios (95% CI) of AF were 1.0 (reference), 0.85 (0.71-1.02), 1.07 (0.88-1.30), 0.93 (0.74-1.17), 0.85 (0.74-0.98), 0.86 (0.76-0.97), and 0.96 (0.80-1.14) for coffee consumption of rarely/never, <= 1 cup/week, 2 to 4 cups/week, 5 to 6 cups/week, 1 cup/day, 2 to 3 cups/day, and 4+ cups/day, respectively; adjusting for age, smoking, alcohol intake, and exercise (P for nonlinear trend 0.01). In a secondary analysis the multivariable adjusted hazard ratio (95% CI) of AF per standard deviation (149-mg) change in caffeine intake was 0.97 (0.92-1.02). Conclusions-Our data suggest a lower risk of AF among men who reported coffee consumption of 1 to 3 cups/day.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cardiac & Cardiovascular Systems

Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence

JoAnn E. Manson, Shari S. Bassuk, Nancy R. Cook, I-Min Lee, Samia Mora, Christine M. Albert, Julie E. Buring

CIRCULATION RESEARCH (2020)

Article Public, Environmental & Occupational Health

Association of Dietary Magnesium Intake with Fatal Coronary Heart Disease and Sudden Cardiac Death

Jason Li, Kathleen M. Hovey, Christopher A. Andrews, Abdullah Quddus, Matthew A. Allison, Linda Van Horn, Lisa W. Martin, Elena Salmoirago-Blotcher, Yiqing Song, JoAnn E. Manson, Christine M. Albert, Bing Lu, Charles B. Eaton

JOURNAL OF WOMENS HEALTH (2020)

Article Cardiac & Cardiovascular Systems

Estimating Myocardial Infarction Size With a Simple Electrocardiographic Marker Score

Daniel C. Lee, Christine M. Albert, Dhiraj Narula, Alan H. Kadish, Gopi Krishna Panicker, Edwin Wu, Andi Schaechter, Julie Pester, Neal A. Chatterjee, Nancy R. Cook, Jeffrey J. Goldberger

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Cardiac & Cardiovascular Systems

Exercise-Related Acute Cardiovascular Events and Potential Deleterious Adaptations Following Long-Term Exercise Training: Placing the Risks Into Perspective-An Update: A Scientific Statement From the American Heart Association

Barry A. Franklin, Paul D. Thompson, Salah S. Al-Zaiti, Christine M. Albert, Marie-France Hivert, Benjamin D. Levine, Felipe Lobelo, Kushal Madan, Anjail Z. Sharrief, Thijs M. H. Eijsvogels

CIRCULATION (2020)

Article Cardiac & Cardiovascular Systems

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

Archana Ramireddy, Harpriya Chugh, Kyndaron Reinier, Joseph Ebinger, Eunice Park, Michael Thompson, Eugenio Cingolani, Susan Cheng, Eduardo Marban, Christine M. Albert, Sumeet S. Chugh

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Cardiac & Cardiovascular Systems

Markers of Myocardial Stress, Myocardial Injury, and Subclinical Inflammation and the Risk of Sudden Death

Brendan M. Everett, M. V. Moorthy, Jani T. Tikkanen, Nancy R. Cook, Christine M. Albert

CIRCULATION (2020)

Editorial Material Cardiac & Cardiovascular Systems

Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation A Pilot Randomized Trial

Philipp Krisai, Steffen Blum, Renate B. Schnabel, Christian Sticherling, Michael Kuehne, Stefanie von Felten, Peter Ammann, Etienne Pruvot, Christine M. Albert, David Conen

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)

Editorial Material Cardiac & Cardiovascular Systems

The electrocardiogram and sudden death: capturing electrical physiology and arrhythmic substrate

Neal A. Chatterjee, Jani T. Tikkanen, Christine M. Albert

EUROPEAN HEART JOURNAL (2020)

Article Multidisciplinary Sciences

Pre-existing traits associated with Covid-19 illness severity

Joseph E. Ebinger, Natalie Achamallah, Hongwei Ji, Brian L. Claggett, Nancy Sun, Patrick Botting, Trevor-Trung Nguyen, Eric Luong, Elizabeth H. Kim, Eunice Park, Yunxian Liu, Ryan Rosenberry, Yuri Matusov, Steven Zhao, Isabel Pedraza, Tanzira Zaman, Michael Thompson, Koen Raedschelders, Anders H. Berg, Jonathan D. Grein, Paul W. Noble, Sumeet S. Chugh, C. Noel Bairey Merz, Eduardo Marban, Jennifer E. Van Eyk, Scott D. Solomon, Christine M. Albert, Peter Chen, Susan Cheng

PLOS ONE (2020)

Review Cardiac & Cardiovascular Systems

Effect of Long-Term Marine-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

Baris Gencer, Luc Djousse, Omar T. Al-Ramady, Nancy R. Cook, JoAnn E. Manson, Christine M. Albert

Summary: In randomized controlled trials examining cardiovascular outcomes, supplementation of marine -3 fatty acids was associated with an increased risk of atrial fibrillation (AF). The risk appeared to be greater in trials testing >1 g/d.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Arrhythmias in Female Patients: Incidence, Presentation and Management

Emily P. Zeitler, Jeanne E. Poole, Christine M. Albert, Sana M. Al-Khatib, Fatima Ali-Ahmed, Ulrika Birgersdotter-Green, Yong-Mei Cha, Mina K. Chung, Anne B. Curtis, Jodie L. Hurwitz, Rachel Lampert, Roopinder K. Sandhu, Fatima Shaik, Erin Sullivan, Kamala P. Tamirisa, Annabelle Santos Volgman, Jennifer M. Wright, Andrea M. Russo

Summary: This review highlights the importance of recognizing gender differences in cardiovascular conditions and emphasizes the need to establish stronger clinical evidence for female treatment. It discusses known or suggested gender differences in arrhythmia care, aiming to optimize care for female patients. Recommendations for improving female enrollment in clinical trials and areas for future research in optimizing arrhythmia care are also provided.

CIRCULATION RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Sex-Specific Temporal Trends in Hypertensive Crisis Hospitalizations in the United States

Joseph E. Ebinger, Yunxian Liu, Matthew Driver, Hongwei Ji, C. Noel Bairey Merz, Florian Rader, Christine M. Albert, Susan Cheng

Summary: Despite improvements in overall hypertension control, hospitalization rates for hypertensive crises, especially among men, have steadily increased, along with an increase in the burden of cardiovascular conditions.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Genetics & Heredity

Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing

Fang Chen, Xingyan Wang, Seon-Kyeong Jang, Bryan C. Quach, J. Dylan Weissenkampen, Chachrit Khunsriraksakul, Lina Yang, Renan Sauteraud, Christine M. Albert, Nicholette D. D. Allred, Donna K. Arnett, Allison E. Ashley-Koch, Kathleen C. Barnes, R. Graham Barr, Diane M. Becker, Lawrence F. Bielak, Joshua C. Bis, John Blangero, Meher Preethi Boorgula, Daniel Chasman, Sameer Chavan, Yii-Der Chen, Lee-Ming Chuang, Adolfo Correa, Joanne E. Curran, Sean P. David, Lisa de Las Fuentes, Ranjan Deka, Ravindranath Duggirala, Jessica D. Faul, Melanie E. Garrett, Sina A. Gharib, Xiuqing Guo, Michael E. Hall, Nicola L. Hawley, Jiang He, Brian D. Hobbs, John E. Hokanson, Chao A. Hsiung, Shih-Jen Hwang, Thomas M. Hyde, Marguerite R. Irvin, Andrew E. Jaffe, Eric O. Johnson, Robert Kaplan, Sharon L. R. Kardia, Joel D. Kaufman, Tanika N. Kelly, Joel E. Kleinman, Charles Kooperberg, I-Te Lee, Daniel Levy, Sharon M. Lutz, Ani W. Manichaikul, Lisa W. Martin, Olivia Marx, Stephen T. McGarvey, Ryan L. Minster, Matthew Moll, Karine A. Moussa, Take Naseri, Kari E. North, Elizabeth C. Oelsner, Juan M. Peralta, Patricia A. Peyser, Bruce M. Psaty, Nicholas Rafaels, Laura M. Raffield, Muagututi'a Sefuiva Reupena, Stephen S. Rich, Jerome Rotter, David A. Schwartz, Aladdin H. Shadyab, Wayne H-H Sheu, Mario Sims, Jennifer A. Smith, Xiao Sun, Kent D. Taylor, Marilyn J. Telen, Harold Watson, Daniel E. Weeks, David R. Weir, Lisa R. Yanek, Kendra A. Young, Kristin L. Young, Wei Zhao, Dana B. Hancock, Bibo Jiang, Scott Vrieze, Dajiang J. Liu

Summary: Most TWASs conducted so far have focused on European ancestry and lacked diversity. To address this limitation, researchers aggregated GWAS summary statistics, whole-genome sequences, and eQTL data from diverse ancestries. They developed a new approach called TESLA, which integrates eQTL datasets with multi-ancestry GWAS, improving power and identifying more genes associated with tobacco use phenotypes compared to alternative TWAS methods. The study also suggests potential drug repurposing options for treating nicotine addiction.

NATURE GENETICS (2023)

Review Cardiac & Cardiovascular Systems

Epidemiology and modifiable risk factors for atrial fibrillation

Adrian D. Elliott, Melissa E. Middeldorp, Isabelle C. Van Gelder, Christine M. Albert, Prashanthan Sanders

Summary: The global prevalence of atrial fibrillation (AF) has significantly increased over the past three decades to approximately 60 million cases. Various risk factors, including lifestyle choices, can modify the lifetime risk of AF. This review provides evidence on the epidemiology of AF, both non-modifiable and modifiable risk factors, and strategies for primary and secondary prevention. It also discusses potential interventions to reduce the frequency and severity of subsequent AF episodes and proposes strategies and global policy changes for the prevention and management of AF.

NATURE REVIEWS CARDIOLOGY (2023)

Correction Cardiac & Cardiovascular Systems

Epidemiology and modifiable risk factors for atrial fibrillation (Jan ,10.1038/s41569-022-00820-8, 2023)

Adrian D. Elliott, Melissa E. Middeldorp, Isabelle C. Van Gelder, Christine M. Albert, Prashanthan Sanders

NATURE REVIEWS CARDIOLOGY (2023)

暂无数据